PRCP and cancer: Most of these proteins are recognized as potential prognostic biomarkers in liver (TFRC and GPLD1), renal (IGHG1, PRCP, SAA1/2, and IL1RAP) and digestive (PRSS3) cancers in the Human Protein Atlas database.